Puma Biotechnology Inc (PBYI)
4.81
+0.02
(+0.42%)
USD |
NASDAQ |
May 10, 16:00
4.81
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Revenue (TTM): 226.63M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 226.63M |
| December 31, 2023 | 235.64M |
| September 30, 2023 | 229.13M |
| June 30, 2023 | 230.12M |
| March 31, 2023 | 235.07M |
| December 31, 2022 | 228.03M |
| September 30, 2022 | 217.71M |
| June 30, 2022 | 206.86M |
| March 31, 2022 | 200.72M |
| December 31, 2021 | 253.16M |
| September 30, 2021 | 250.36M |
| June 30, 2021 | 254.86M |
| Date | Value |
|---|---|
| March 31, 2021 | 272.06M |
| December 31, 2020 | 225.11M |
| September 30, 2020 | 235.48M |
| June 30, 2020 | 241.07M |
| March 31, 2020 | 224.41M |
| December 31, 2019 | 272.26M |
| September 30, 2019 | 280.42M |
| June 30, 2019 | 286.69M |
| March 31, 2019 | 283.54M |
| December 31, 2018 | 250.99M |
| September 30, 2018 | 201.52M |
| June 30, 2018 | 144.97M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
200.72M
Minimum
Mar 2022
286.69M
Maximum
Jun 2019
240.29M
Average
235.27M
Median
Revenue (TTM) Benchmarks
| ADMA Biologics Inc | 258.22M |
| Pfizer Inc | 55.09B |
| Sarepta Therapeutics Inc | 1.403B |
| Immunogen Inc (DELISTED) | 287.61M |
| United Therapeutics Corp | 2.498B |